Inventor · Toronto, ON, CA

John E. Davies

18Patents
7h-index
14Co-inventors
63Inventor score

Filing activity: Oct 6, 1976 → Oct 15, 2015

Most-cited inventions

PatentTitleAreaCited byStatus
US6472210B1 Polymer scaffold having microporous polymer struts defining interconnected macropores Chemistry; Metallurgy 72 Expired
US6379962B1 Polymer scaffold having microporous polymer struts defining interconnected macropores Human Necessities 67 Expired
US6875442B2 Process for growing tissue in a biocompatible macroporous polymer scaffold and products therefrom Chemistry; Metallurgy 53 Expired
US7022522B2 Macroporous polymer scaffold containing calcium phosphate particles Chemistry; Metallurgy 52 Expired
US8278102B2 Viable cells from frozen umbilical cord tissue Human Necessities 20 Active
US4077832A Epitaxial growth of bismuth rare earth iron garnet from a flux of bismuth oxide and alkali metal oxide Chemistry; Metallurgy 18 Expired
US7547546B2 Progenitor cells from wharton's jelly of human umbilical cord Chemistry; Metallurgy 11 Expired
US8790923B2 Viable cells from frozen umbilical cord tissue Human Necessities 7 Active
US5849569A Assessment of bone cell activity Chemistry; Metallurgy 4 Expired
US9644182B2 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom Chemistry; Metallurgy 4 Active
US4190683A Method for forming a liquid phase epitaxial film on a wafer Electricity 3 Expired
US8481311B2 Progenitor cells from wharton's jelly of human umbilical cord Chemistry; Metallurgy 2 Active
US8900573B2 Immune privileged and modulatory progenitor cells Chemistry; Metallurgy 2 Active
US9611456B2 Progenitor cells from wharton'S jelly of human umbilical cord Chemistry; Metallurgy 1 Active
US8277794B2 Immune privileged and modulatory progenitor cells Chemistry; Metallurgy 1 Active
US9567564B2 Progenitor cells from Wharton's jelly of human umbilical cord Chemistry; Metallurgy 1 Active
US9005599B2 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents Emerging Cross-Sectional Technologies 0 Active
US9498544B2 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.